Project Details
| Status | Active |
|---|---|
| Effective start/end date | 21/11/13 → … |
PROSPER - Phase 3, randomized double-blind placebo-controlled study of Enzalutamide in patients with nonmetastatic castration-resistant prostate cancer
- Gurney, Howard (Primary Chief Investigator)
Project: Research